The deubiquitinase USP36 Regulates DNA replication stress and confers therapeutic resistance through PrimPol stabilization. Issue 22 (25th November 2020)

• Record Type: Journal Article
• Authors: Yan, Yuanliang; Xu, Zhijie; Huang, Jinzhou; Guo, Guijie; Gao, Ming; Kim, Wootae; Zeng, Xiangyu; Kloeber, Jake A; Zhu, Qian; Zhao, Fei; Luo, Kuntian; Lou, Zhenkun
• Is Part Of: Nucleic acids research. Volume 48:Issue 22(2020)
• Page Start: 12711
• Page End: 12726
• Publication Date: 2020-11-25
• Subjects: Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 572.805
• DOI: 10.1093/nar/gkaa1090
• Languages: English
• ISSNs: 0305-1048

Abstract

Abstract: PrimPol has been recently identified as a DNA damage tolerant polymerase that plays an important role in replication stress response. However, the regulatory mechanisms of PrimPol are not well defined. In this study, we identify that the deubiquitinase USP36 interferes with degradation of PrimPol to regulate the replication stress response. Mechanistically, USP36 is deubiquitinated following DNA replication stress, which in turn facilitates its upregulation and interaction with PrimPol. USP36 deubiquitinates K29-linked polyubiquitination of PrimPol and increases its protein stability. Depletion of USP36 results in replication stress-related defects and elevates cell sensitivity to DNA-damage agents, such as cisplatin and olaparib. Moreover, USP36 expression positively correlates with the level of PrimPol protein and poor prognosis in patient samples. These findings indicate that the regulation of PrimPol K29-linked ubiquitination by USP36 plays a critical role in DNA replication stress and chemotherapy response.